(NASDAQ: IVVD) Invivyd's forecast annual revenue growth rate of 204.3% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.84%.
Invivyd's revenue in 2025 is $11,564,000.On average, 2 Wall Street analysts forecast IVVD's revenue for 2025 to be $20,591,900,425, with the lowest IVVD revenue forecast at $13,396,995,920, and the highest IVVD revenue forecast at $27,786,804,931. On average, 1 Wall Street analysts forecast IVVD's revenue for 2026 to be $29,688,699,887, with the lowest IVVD revenue forecast at $29,688,699,887, and the highest IVVD revenue forecast at $29,688,699,887.
In 2027, IVVD is forecast to generate $39,018,750,617 in revenue, with the lowest revenue forecast at $39,018,750,617 and the highest revenue forecast at $39,018,750,617.